{{Rsnum
|rsid=5751862
|Gene=SPECC1L
|Chromosome=22
|position=24406596
|Orientation=plus
|GMAF=0.4169
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SPECC1L,SPECC1L-ADORA2A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 20.7 | 52.3 | 27.0
| HCB | 21.2 | 54.0 | 24.8
| JPT | 30.4 | 48.2 | 21.4
| YRI | 0.0 | 22.4 | 77.6
| ASW | 3.5 | 28.1 | 68.4
| CHB | 21.2 | 54.0 | 24.8
| CHD | 27.8 | 40.7 | 31.5
| GIH | 3.0 | 32.0 | 65.0
| LWK | 6.4 | 39.1 | 54.5
| MEX | 32.8 | 50.0 | 17.2
| MKK | 11.6 | 34.8 | 53.5
| TSI | 20.6 | 51.0 | 28.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20334879
|Title=Adenosine A(2A) receptor gene: Evidence for association of risk variants with panic disorder and anxious personality
}}

{{PMID Auto
|PMID=18305461
|Title=Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}